197 related articles for article (PubMed ID: 27476888)
1. Defective natural killer cell activity in a mouse model of eczema herpeticum.
Kawakami Y; Ando T; Lee JR; Kim G; Kawakami Y; Nakasaki T; Nakasaki M; Matsumoto K; Choi YS; Kawakami T
J Allergy Clin Immunol; 2017 Mar; 139(3):997-1006.e10. PubMed ID: 27476888
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.
Kawakami Y; Tomimori Y; Yumoto K; Hasegawa S; Ando T; Tagaya Y; Crotty S; Kawakami T
J Exp Med; 2009 Jun; 206(6):1219-25. PubMed ID: 19468065
[TBL] [Abstract][Full Text] [Related]
3. The Genetics of Eczema Herpeticum.
Hodara E; Ong PY
Clin Rev Allergy Immunol; 2022 Dec; 63(3):390-397. PubMed ID: 36114947
[TBL] [Abstract][Full Text] [Related]
4. Immunological studies of herpes simplex virus infection in children with atopic eczema.
Goodyear HM; McLeish P; Randall S; Buchan A; Skinner GR; Winther M; Rolland J; Morgan G; Harper JI
Br J Dermatol; 1996 Jan; 134(1):85-93. PubMed ID: 8745891
[TBL] [Abstract][Full Text] [Related]
5. Eczema Herpeticum: Clinical and Pathophysiological Aspects.
Damour A; Garcia M; Seneschal J; Lévêque N; Bodet C
Clin Rev Allergy Immunol; 2020 Aug; 59(1):1-18. PubMed ID: 31836943
[TBL] [Abstract][Full Text] [Related]
6. Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions.
Takahashi R; Sato Y; Kurata M; Yamazaki Y; Kimishima M; Shiohara T
J Immunol; 2014 Feb; 192(3):969-78. PubMed ID: 24379126
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
[TBL] [Abstract][Full Text] [Related]
8. Severe eczema herpeticum is associated with prolonged depression of cell-mediated immunity to herpes simplex virus.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Curr Probl Dermatol; 1989; 18():158-61. PubMed ID: 2545414
[TBL] [Abstract][Full Text] [Related]
9. Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients.
Seegräber M; Worm M; Werfel T; Svensson A; Novak N; Simon D; Darsow U; Augustin M; Wollenberg A
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1074-1079. PubMed ID: 31733162
[TBL] [Abstract][Full Text] [Related]
10. Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum.
Bin L; Li X; Richers B; Streib JE; Hu JW; Taylor P; Leung DYM
J Allergy Clin Immunol; 2018 Jun; 141(6):2085-2093.e1. PubMed ID: 29371118
[TBL] [Abstract][Full Text] [Related]
11. Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum.
Staudacher A; Hinz T; Novak N; von Bubnoff D; Bieber T
Allergy; 2015 Nov; 70(11):1432-9. PubMed ID: 26198597
[TBL] [Abstract][Full Text] [Related]
12. Darier Disease Presenting with Recurrent Kaposi Varicelliform Eruption in a 10-year-old Boy with Seborrheic Dermatitis.
Navratil M; Ožanić Bulić S; Pustišek N; Ulamec M; Kralj R
Acta Dermatovenerol Croat; 2021 Nov; 29(4):238-240. PubMed ID: 36896697
[TBL] [Abstract][Full Text] [Related]
13. Eczema herpeticum in atopic dermatitis.
Traidl S; Roesner L; Zeitvogel J; Werfel T
Allergy; 2021 Oct; 76(10):3017-3027. PubMed ID: 33844308
[TBL] [Abstract][Full Text] [Related]
14. Cathelicidin deficiency predisposes to eczema herpeticum.
Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
[TBL] [Abstract][Full Text] [Related]
15. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.
Wollenberg A; Zoch C; Wetzel S; Plewig G; Przybilla B
J Am Acad Dermatol; 2003 Aug; 49(2):198-205. PubMed ID: 12894065
[TBL] [Abstract][Full Text] [Related]
16. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.
Leung DY; Gao PS; Grigoryev DN; Rafaels NM; Streib JE; Howell MD; Taylor PA; Boguniewicz M; Canniff J; Armstrong B; Zaccaro DJ; Schneider LC; Hata TR; Hanifin JM; Beck LA; Weinberg A; Barnes KC
J Allergy Clin Immunol; 2011 Apr; 127(4):965-73.e1-5. PubMed ID: 21458658
[TBL] [Abstract][Full Text] [Related]
17. Detection of Herpes simplex virus DNA in non-herpetic areas of patients with eczema herpeticum.
Amatsu A; Yoshida M
Dermatology; 2000; 200(2):104-7. PubMed ID: 10773695
[TBL] [Abstract][Full Text] [Related]
18. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Knitlova J; Hajkova V; Voska L; Elsterova J; Obrova B; Melkova Z
PLoS One; 2014; 9(12):e114374. PubMed ID: 25486419
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis and clinical implications of eczema herpeticum.
Bussmann C; Peng WM; Bieber T; Novak N
Expert Rev Mol Med; 2008 Jul; 10():e21. PubMed ID: 18620613
[TBL] [Abstract][Full Text] [Related]
20. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.
Gao PS; Rafaels NM; Hand T; Murray T; Boguniewicz M; Hata T; Schneider L; Hanifin JM; Gallo RL; Gao L; Beaty TH; Beck LA; Barnes KC; Leung DY
J Allergy Clin Immunol; 2009 Sep; 124(3):507-13, 513.e1-7. PubMed ID: 19733298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
